Results 171 to 180 of about 45,933 (222)

Breast cancer-associated fibroblast-derived exosomal miR-1290 promotes triple-negative breast cancer cell proliferation. [PDF]

Signal Transduct Target Ther
Lee J, Son T, Kim G, Lee HW, Tae IH, Kang Y, Lee J, Kim J, Lee SG, Han TH, Ban HS, Park K, Jung CR, Lim JH, Son MY, Kim DS, Hur K, Han TS, Cho HS.   +18 more
europepmc   +1 more source

IV-EVE: EVE for Injection-ADME, Pharmacokinetic and Toxicological Evaluation for Novel Deciparticle EVE Formulation. [PDF]

Biomedicines
Chang WH, Chang N, Min SH, Lopp JM, Hoff R, Hoque T, Trieu V, Lee C.   +7 more
europepmc   +1 more source

Efficacy of everolimus and letrozole with or without ribociclib in recurrent endometrial cancer: a phase 2 randomized clinical trial. [PDF]

Nat Commun
How JA, Westin SN, Pham M, Lawson B, Chen M, Tandon N, Yuan Y, Zhang R, Jazaeri AA, Sood AK, Onstad Grinsfelder M, Schmeler KM, Vining DJ, Fix SM, Dai Y, Bowen MB, Lu KH, Yates MS, Broaddus R, Soliman PT.   +19 more
europepmc   +1 more source

Intravenous Everolimus Formulation (Sapu003) for Clinical Trials. [PDF]

Int J Mol Sci
Min SH, Forero K, Putnam W, Anderson J, Hoff R, Lopp J, Trieu V, Ho K, Lee C.   +8 more
europepmc   +1 more source

Ten-Year Disease Control of Metastatic Pancreatic Neuroendocrine Tumour Treated With Everolimus. [PDF]

Cureus
Machete M, Silva BM, Simões P, Leal-Costa L, Teixeira JA.   +4 more
europepmc   +1 more source

[Everolimus inhibits malignant phenotype of erdafitinib-resistant bladder cancer cells through the p70S6K/PI3K/MAPK signaling pathway]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Wu H, Jiang Y, Zhang X, Wang S.
europepmc   +1 more source

23 years of mTOR inhibition for tuberous sclerosis: Practical considerations. [PDF]

Neurotherapeutics
Franz DN.
europepmc   +1 more source

The Role of mTOR Inhibitors in CMV Prevention: An Overlooked Aspect of the Fourth International CMV Consensus Guidelines. [PDF]

Transplantation
Nashan B.
europepmc   +1 more source

Real-world long-term outcomes of clopidogrel-based dual antiplatelet therapy post-drug-eluting stent implantation in all comers patients: A retrospective evaluation. [PDF]

Am Heart J Plus
Parikh R, Langade J, Langade D.
europepmc   +1 more source

Early use of everolimus for neonatal cardiac rhabdomyoma: a pharmacotherapeutic case with pharmacist-led monitoring. [PDF]

Saudi Pharm J
Alsharhan M, Alkhezi OS, Alfayez OM.
europepmc   +1 more source